Cargando…

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1

Detalles Bibliográficos
Autores principales: Yu, Haisheng, Guo, Pengle, Yang, Yingyin, Dai, Jun, Tang, Xiaoping, Li, Linghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508509/
https://www.ncbi.nlm.nih.gov/pubmed/37592413
http://dx.doi.org/10.1097/CM9.0000000000002810
_version_ 1785107552481050624
author Yu, Haisheng
Guo, Pengle
Yang, Yingyin
Dai, Jun
Tang, Xiaoping
Li, Linghua
author_facet Yu, Haisheng
Guo, Pengle
Yang, Yingyin
Dai, Jun
Tang, Xiaoping
Li, Linghua
author_sort Yu, Haisheng
collection PubMed
description
format Online
Article
Text
id pubmed-10508509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-105085092023-09-20 A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1 Yu, Haisheng Guo, Pengle Yang, Yingyin Dai, Jun Tang, Xiaoping Li, Linghua Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-08-17 2023-09-20 /pmc/articles/PMC10508509/ /pubmed/37592413 http://dx.doi.org/10.1097/CM9.0000000000002810 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Yu, Haisheng
Guo, Pengle
Yang, Yingyin
Dai, Jun
Tang, Xiaoping
Li, Linghua
A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title_full A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title_fullStr A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title_full_unstemmed A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title_short A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
title_sort three-dose inactivated sars-cov-2 vaccine is sufficient to elicit humoral immune responses in people living with hiv-1
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508509/
https://www.ncbi.nlm.nih.gov/pubmed/37592413
http://dx.doi.org/10.1097/CM9.0000000000002810
work_keys_str_mv AT yuhaisheng athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT guopengle athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT yangyingyin athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT daijun athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT tangxiaoping athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT lilinghua athreedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT yuhaisheng threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT guopengle threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT yangyingyin threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT daijun threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT tangxiaoping threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1
AT lilinghua threedoseinactivatedsarscov2vaccineissufficienttoelicithumoralimmuneresponsesinpeoplelivingwithhiv1